ICM
BTG icon

Invenomic Capital Management’s B2Gold BTG Stock Holding History

Invenomic Capital Management’s Portfolio BTG Stock Details BTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-990,484
Closed -$4.9M – 153
2025
Q3 		$4.9M Buy
990,484
+252,092
+34% +$991K 0.24% 101
2025
Q2 		$2.67M Sell
738,392
-134,102
-15% -$440K 0.15% 127
2025
Q1 		$2.49M Sell
872,494
-243,995
-22% -$655K 0.13% 145
2024
Q4 		$2.72M Buy
1,116,489
+260,645
+30% +$765K 0.13% 137
2024
Q3 		$2.64M Buy
+855,844
New +$2.49M 0.14% 128
2023
Q4 		– Sell
-5,859,005
Closed -$16.8M – 178
2023
Q3 		$16.8M Sell
5,859,005
-320,716
-5% -$1.04M 0.71% 43
2023
Q2 		$22M Buy
6,179,721
+1,402,288
+29% +$5.49M 1.12% 32
2023
Q1 		$18.9M Buy
4,777,433
+1,654,813
+53% +$6.16M 1.07% 35
2022
Q4 		$11.1M Buy
3,122,620
+1,532,711
+96% +$5.1M 0.75% 44
2022
Q3 		$5.1M Sell
1,589,909
-2,969,574
-65% -$9.79M 0.44% 75
2022
Q2 		$15.4M Buy
4,559,483
+4,483,820
+5,926% +$18.7M 1.09% 24
2022
Q1 		$347K Buy
+75,663
New +$304K 0.04% 150

Other funds holding BTG

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Invenomic Capital Management's BTG Position: Q4 2025 in Review

Invenomic Capital Management sold out of B2Gold (BTG) in Q4 2025, closing a stake of 990,484 shares — an estimated $4.9M sold.

Invenomic Capital Management first reported a position in BTG in Q1 2022 and held it in 12 quarters. The position peaked at $22M in Q2 2023. 291 funds tracked by Wall St. Rank hold BTG as of Q4 2025.

  • Invenomic Capital Management reported no remaining B2Gold position as of Q4 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 990,484 B2Gold shares in Q4 2025, an estimated $4.9M.
  • Invenomic Capital Management first reported a position in B2Gold in Q1 2022 and held it in 12 quarters.
  • Invenomic Capital Management's B2Gold position peaked at $22M in Q2 2023.
  • 291 funds tracked by Wall St. Rank held B2Gold as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.